FDA Approves METFORMIN HYDROCHLORIDE — PuraCap Laboratories LLC dba Blu Pharmaceuticals
PuraCap Laboratories LLC dba Blu Pharmaceuticals announced Wednesday the approval of its ANDA for Metformin Hydrochloride, a generic oral drug. This development underscores the sustained demand in the generic market and provides a competitive expansion for Blu Pharmaceuticals alongside its portfolio of oral pills.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day